Global impact of pandemic by SARS-CoV-2 on breast cancer diagnosis and screening
Mastology (Impr.)
;
32: 1-5, 2022.
Article
in English
|
LILACS-Express
| LILACS
| ID: biblio-1380409
ABSTRACT
Introduction:
The pandemic related to the new coronavirus is characterized by high rates of contamination, transmissibility, and mortality. The measures of social isolation adopted by the World Health Organization and corroborated by several countries, with a view to avoiding or minimizing the transmission of COVID-19, can lead to the reduction of the capacity of screening and diagnosis of diseases, such as breast cancer.Objective:
This study aimed to analyze the diagnostic indexes and mamaria malignancy diagnosis test, such as mammogram, during the COVID-19 pandemic period.Methodology:
Systematic review of the literature based on studies found in the PubMed, SciELO, LILACS, and ScienceDirect databases.Results:
The six selected articles demonstrate a reduction in the diagnosis of breast cancer during the pandemic, although with discordant rates. Outcomes such as reduced number of mammograms and change in tumor stage were also analyzed.Conclusion:
It is essential to maintain care with the screening, diagnosis, and treatment of breast cancer, in order to minimize the damage caused over more than 1 year of COVID-19 pandemic.
Full text:
Available
Index:
LILACS (Americas)
Type of study:
Diagnostic study
/
Screening study
Language:
English
Journal:
Mastology (Impr.)
Journal subject:
Neoplasias da Mama
Year:
2022
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal Fronteira Sul/BR
/
Universidade de Passo Fundo/BR
Similar
MEDLINE
...
LILACS
LIS